MAPT and neurodegenerative disease: The data indicated that in microglia, Acat1/Soat1 is significantly elevated in many neurodegenerative diseases, including several AD mouse models (in both AβPP and tau models), acute inflammation/infection mouse models, and a mouse model for aging (22 months of age).